Ads
related to: carboplatin chemotherapy- Diagnosis Can Be A Shock
View Site To See Info About A
Treatment & Learn About BTCs.
- Treatment Option
BTC Patients & Caregivers: Learn
More About A Treatment Option.
- Dosing Info For Patients
See Dosing And Administration Info
For A Biliary Tract Cancer Therapy.
- Register For Support
Sign Up For Educational Resources
For A Biliary Tract Cancer Therapy.
- Patient & Caregiver Site
Learn About An Approved
Treatment For Biliary Tract Cancer.
- Access Support Resources
Get Support. View Resources For A
Biliary Tract Cancer Treatment.
- Diagnosis Can Be A Shock
Search results
Cullinan Therapeutics announces success for zipalertinib as combo therapy
Clinical Trials Arena via Yahoo Finance· 15 hours agoEGFR is overexpressed in tumour cells and involved in cell proliferation. Johnson & Johnson’s...
ASCO24: Akeso’s bispecific vvonescimab faces a rocky road ahead in NSCLC
Pharmaceutical Technology via Yahoo Finance· 2 days agoCompared to the chemotherapy control, ivonescimab plus...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 7 hours agoLate-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib show clinically meaningful antitumor response and improved safety profile in patients with ...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 17 hours agoThe therapy was evaluated as a monotherapy and in combination with AbbVie’s investigative programmed...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 4 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors
Medical Xpress· 6 hours agoThe studies were featured in an oral abstract session highlighting the development of new molecularly targeted agents. Preliminary data from a Phase I study evaluating the novel antibody-drug ...
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related...
The Parsons Sun· 3 days agoJohnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with locally advanced or metastatic ...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 6 days agoParticipants were assigned in a 2:1 ratio to receive either KEYTRUDA with chemotherapy or a...
Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting...
Morningstar· 2 days agoLUND, SWEDEN / ACCESSWIRE / June 1, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today gave a presentation at the ASCO conference showing clinical data on nadunolimab counteracting the serious problem of chemotherapy
Carefully Designing De-escalation Trials in Breast Cancer
Medscape· 5 days agoDe-escalation trials in early breast cancer are "critical to preserving quality of life" but require...
Ads
related to: carboplatin chemotherapy